Education
About Us
Working with TipRanks
Follow Us
ONO Pharmaceutical Co Ltd (JP:4528)
:4528
Total Valuation
ONO Pharmaceutical Co has a market cap or net worth of $721.61B. The enterprise value is ¥724.98B.
Market Cap$721.61B
Enterprise Value¥724.98B
Share Statistics
ONO Pharmaceutical Co has 498,692,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding498,692,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ONO Pharmaceutical Co’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 15.70%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)15.70%
Return on Capital Employed (ROCE)0.20
Revenue Per Employee130.46M
Profits Per Employee33.22M
Employee Count3,853
Asset Turnover0.55
Inventory Turnover2.61
Valuation Ratios
The current PE Ratio of ONO Pharmaceutical Co is 9.26. ONO Pharmaceutical Co’s PEG ratio is -0.45.
PE Ratio9.26
PS Ratio0.00
PB Ratio0.90
Price to Fair Value1.49
Price to FCF9.37
Price to Operating Cash Flow7.90
PEG Ratio-0.45
Income Statement
In the last 12 months, ONO Pharmaceutical Co had revenue of 502.67B and earned 127.98B in profits. Earnings per share was 266.61.
Revenue502.67B
Gross Profit375.55B
Operating Income163.10B
Pretax Income163.73B
Net Income127.98B
EBITDA181.98B
Earnings Per Share (EPS)266.61
Cash Flow
In the last 12 months, operating cash flow was 92.63B and capital expenditures -14.55B, giving a free cash flow of 78.08B billion.
Operating Cash Flow92.63B
Free Cash Flow78.08B
Free Cash Flow per Share156.57
Dividends & Yields
ONO Pharmaceutical Co pays an annual dividend of ¥40, resulting in a dividend yield of 5.11%
Dividend Per Share¥40
Dividend Yield5.11%
Payout Ratio37.54%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.41
52-Week Price Change-28.17%
50-Day Moving Average1.62K
200-Day Moving Average1.74K
Relative Strength Index (RSI)44.29
Average Volume (3m)2.56M
Important Dates
ONO Pharmaceutical Co upcoming earnings date is Aug 4, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 4, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
ONO Pharmaceutical Co as a current ratio of 3.99, with Debt / Equity ratio of 18.91%
Current Ratio3.99
Quick Ratio3.52
Debt to Market Cap0.00
Net Debt to EBITDA-0.86
Interest Coverage Ratio712.24
Taxes
In the past 12 months, ONO Pharmaceutical Co has paid 35.69B in taxes.
Income Tax35.69B
Effective Tax Rate0.22
Enterprise Valuation
ONO Pharmaceutical Co EV to EBITDA ratio is 5.65, with an EV/FCF ratio of 11.44.
EV to Sales2.04
EV to EBITDA5.65
EV to Free Cash Flow11.44
EV to Operating Cash Flow9.29
Balance Sheet
ONO Pharmaceutical Co has $170.84B in cash and marketable securities with ¥154.29B in debt, giving a net cash position of -$16.55B billion.
Cash & Marketable Securities$170.84B
Total Debt¥154.29B
Net Cash-$16.55B
Net Cash Per Share-$33.19
Tangible Book Value Per Share$1.54K
Margins
Gross margin is 72.43%, with operating margin of 32.45%, and net profit margin of 25.46%.
Gross Margin72.43%
Operating Margin32.45%
Pretax Margin32.57%
Net Profit Margin25.46%
EBITDA Margin36.20%
EBIT Margin32.62%
Analyst Forecast
The average price target for ONO Pharmaceutical Co is $1,399.60, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$1,399.60
Price Target Upside-9.32% Downside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast-2.16%
EPS Growth Forecast-40.39%